Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo
- PMID: 17522702
- PMCID: PMC2292406
- DOI: 10.1038/sj.jid.5700903
Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures
Comment in
-
Comment on "Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo".J Invest Dermatol. 2008 Jun;128(6):1581; author reply 1583-4. doi: 10.1038/sj.jid.5701220. J Invest Dermatol. 2008. PMID: 18478015 No abstract available.
-
Comment on "Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo".J Invest Dermatol. 2008 Jun;128(6):1582-3; author reply 1583-4. doi: 10.1038/sj.jid.5701221. J Invest Dermatol. 2008. PMID: 18478016 No abstract available.
References
-
- Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127:179–182. - PubMed
-
- Bodnar AG, Ouellette M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352. - PubMed
-
- Bowen AR, Hanks AN, et al. Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol. 2003;120:48–55. - PubMed
-
- Brunk U, Ericsson JL, Ponten J, Westermark B. Residual bodies and “aging” in cultured human glia cells. Effect of entrance into phase 3 and prolonged periods of confluence. Exp Cell Res. 1973;79:1–27. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
